1095 Pharmacogenomic analysis of the triplet combination of gemcitabine, oxaliplatin and cetuximab as salvage therapy for metastatic colorectal cancer (mCRC) patients
E. Bandres, J. Rodriguez, A. Hernandez, N. Bitarte, N. Ramirez, J.A. Diaz-Gonzalez, A. Chopitea, M. Ponz, R.N. Zarate, J. Garcia-FoncillasVolume:
7
Year:
2009
Language:
english
DOI:
10.1016/s1359-6349(09)70388-x
File:
PDF, 49 KB
english, 2009